BHI Weekly News Archives 2000-2022 358th Edition – June 18, 2019 BioHealth Innovation If you are having trouble viewing this email, please click here June 18, 2019 FOUNDING MEMBER OF Rich…Super UserJune 18, 2019
News Rich Bendis Presentation at NCI and FNL Technology Showcase FREDERICK, A KEYPLAYER IN THE BIOHEALTH CAPITAL REGION (more…)Super UserJune 17, 2019
News The Top 10 Highest-Paid Women Executives in Biopharma – Martine Rothblatt, Chairman of United Therapeutics #2 After last year’s BIO International Convention in Boston was overshadowed by reports of topless women dancers bearing the logos of…Super UserJune 17, 2019
News Concept to Clinic: Commercializing Innovation (C3i) Program | National Institute of Biomedical Imaging and Bioengineering The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful…Super UserJune 17, 2019
News Alexandria, Verily Bring Opioid Treatment Campus to Dayton – Connect Media Commercial Real Estate News The first facility has opened at Dayton, OH’s 4.3-acre OneFifteen campus, a treatment center for opioid addiction. The project is…Super UserJune 17, 2019
News RoosterBio Receives Grant from Maryland Stem Cell Research Fund to Commercialize MSC-EV Technology RoosterBio, a regenerative medicine manufacturing technology leader, has received a $300,000 grant from the Maryland Stem Cell Research Commission to…Super UserJune 17, 2019
News Lunch and Learn: Accessing the Virginia Neuroscience Initiative (VNI) Wednesday, June 26, 2019 from 11:45 AM to 1:00 PM EDT Attendees will be provided an overview of Virginia Neuroscience…Super UserJune 17, 2019
News D.C.’s Top Economic Development Official Leaving To Join Amazon D.C.'s top economic development official is leaving government to join Amazon as the tech giant builds its second headquarters in Northern…Super UserJune 17, 2019
News 70 Years of Scientific Research on Diseases 70 Years of Scientific Research on Diseases (1947-2017) - number of research articles published (PubMed) # For more interesting &…Super UserJune 17, 2019
News Corvidia Therapeutics Initiates Phase 2b Dose-Finding Study for Ziltivekimab | Business Wire Corvidia Therapeutics Inc., a clinical stage biotechnology company, announced today the initiation of patient screening for a Phase 2b dose-finding…Super UserJune 17, 2019